Dermapharm Holding SE (ETR:DMP)
Germany · Delayed Price · Currency is EUR 43.00
+1.25 (2.99%)
Jul 29, 2026, 4:36 PM CET
Dermapharm Holding SE Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 195.35 | 183.51 | 172.01 | 106 | 216.3 | 292.98 |
Depreciation & Amortization | 92.37 | 92.01 | 86.79 | 101.77 | 94.91 | 55.16 |
Other Adjustments | 28.55 | 37.2 | 44.49 | 67.98 | 22.05 | -6.65 |
Changes in Income Taxes Payable | -64.75 | -89.89 | -83.84 | -65.37 | -40.59 | -44.85 |
Changes in Other Operating Activities | 33.23 | 6.32 | -18.06 | 9.04 | -4.14 | -46.27 |
Operating Cash Flow | 284.74 | 229.15 | 201.38 | 219.42 | 288.53 | 250.37 |
Operating Cash Flow Growth | 65.05% | 13.79% | -8.22% | -23.95% | 15.24% | 90.98% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -43.89 | -42.12 | -38.24 | -41.54 | -39.01 | -61.2 |
Sale of Property, Plant & Equipment | 0.61 | 0.8 | 3.79 | 2.82 | 0.68 | 2.52 |
Purchases of Investments | - | -10.98 | -0.4 | - | -6.07 | -48.25 |
Proceeds from Sale of Investments | - | 1.17 | 0.71 | 7.95 | 10 | - |
Cash Acquisitions | - | -51.24 | - | -389.4 | -69.79 | -22.51 |
Other Investing Activities | 1.61 | 4.13 | 4.53 | 3.91 | 5.18 | 0.1 |
Investing Cash Flow | -98.06 | -98.24 | -29.61 | -415.43 | -99.01 | -129.35 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | 185 | 170 | 111.17 | 715 | 469.95 | 10 |
Long-Term Debt Repaid | -152.29 | -108.22 | -219.3 | -420.86 | -541.19 | -35.91 |
Net Long-Term Debt Issued (Repaid) | 32.71 | 61.78 | -108.13 | 294.14 | -71.24 | -25.91 |
Common Dividends Paid | - | -48.46 | -47.38 | -56.53 | -116.83 | -47.38 |
Other Financing Activities | -51.3 | -59.43 | -53.66 | -33.07 | -11.69 | -7.69 |
Financing Cash Flow | -74.7 | -46.11 | -209.17 | 204.54 | -199.77 | -80.98 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -1.24 | -2.69 | -0.04 | -0 | -0.15 | 1.07 |
Net Cash Flow | 111.98 | 84.8 | -37.4 | 8.53 | -10.24 | 40.04 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 240.85 | 187.03 | 163.14 | 177.88 | 249.52 | 189.17 |
Free Cash Flow Growth | 83.50% | 14.64% | -8.29% | -28.71% | 31.91% | 109.48% |
FCF Margin | 20.61% | 16.05% | 13.82% | 15.67% | 24.35% | 20.06% |
Free Cash Flow Per Share | 4.48 | 3.47 | 3.03 | 3.30 | 4.63 | 3.51 |
Levered Free Cash Flow | 193.88 | 160.51 | -47.69 | 360.41 | 74.16 | 86.51 |
Unlevered Free Cash Flow | 186.78 | 124.27 | 87.57 | 108.35 | 160.58 | 115.66 |